Johnson & Johnson
- SEC CIK
- 0000200406
- Latest filing
- Aug 6, 2026
Holdings in Q3 2025
Holdings as of Sep 30, 2025, filed Mar 18, 2026. Long positions only; changes compare share counts with Q2 2025.
- Positions
- 20
- 0 vs. Q2 2025
- Portfolio value
- $503.9M
- +$169.8M (+50.8%) vs. Q2 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PTGXProtagonist Therapeutics, Inc | COM | 2,449,183 | $162.7M | 32.3% | 00.0% | Unchanged | History |
| NBTXNanobiotix S.A. | SPONSORED ADS | 5,623,816 | $106.2M | 21.1% | 00.0% | Unchanged | History |
| MGTXMeiraGTx Holdings plc | COM | 6,641,064 | $54.7M | 10.8% | 00.0% | Unchanged | History |
| RAPPRapport Therapeutics, Inc. | COM | 1,784,517 | $53.0M | 10.5% | −713,534−28.6% | Reduced | History |
| CVRXCVRx, Inc. | COM | 4,103,430 | $33.1M | 6.6% | 00.0% | Unchanged | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 814,586 | $26.6M | 5.3% | 00.0% | Unchanged | History |
| CTNMContineum Therapeutics, Inc. | CL A | 1,979,173 | $23.3M | 4.6% | 00.0% | Unchanged | History |
| PRCTPROCEPT BioRobotics Corp | COM | 357,939 | $12.8M | 2.5% | 00.0% | Unchanged | History |
| XNCRXencor Inc | COM | 748,062 | $8.77M | 1.7% | 00.0% | Unchanged | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 247,598 | $8.54M | 1.7% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 3,379,064 | $4.26M | 0.8% | 00.0% | Unchanged | History |
| NMRANeumora Therapeutics, Inc. | COM | 1,849,445 | $3.37M | 0.7% | 00.0% | Unchanged | History |
| VORVor Biopharma Inc. | COM | 53,732 | $2.62M | 0.5% | 00.0% | UnchangedConverted for a 1-for-20 split | History |
| RLYBRallybio Corp | COM | 3,636,363 | $1.81M | 0.4% | 00.0% | Unchanged | History |
| LYELLyell Immunopharma, Inc. | COM NEW | 54,887 | $891.4K | 0.2% | +54,887 | New | History |
| NNOXNano-X Imaging Ltd. | ORD SHS | 158,852 | $587.8K | 0.1% | 00.0% | Unchanged | History |
| LABStandard Biotools Inc. | COM | 311,967 | $405.6K | 0.1% | 00.0% | Unchanged | History |
| ACETAdicet Bio, Inc. | COM | 364,472 | $295.3K | 0.1% | 00.0% | Unchanged | History |
| HLSQTessera Defense & Homeland Security Inc. | COM | 96,866 | $50.9K | <0.1% | 00.0% | Unchanged | History |
| SENSSenseonics Holdings, Inc. | COM | 54,621 | $23.8K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q2 2025 (1)
Positions held at the end of Q2 2025 that are gone from this filing.